Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers October 22, 2017
Pharmacy Choice - Pharmaceutical News - Pfizer Announces FDA Approval Of LYRICA CR Extended-release Tablets CV - October 22, 2017

Pharmacy News Article

 10/12/17 - Pfizer Announces FDA Approval Of LYRICA CR Extended-release Tablets CV

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced the U.S. FDA has approved LYRICA CR (pregabalin) extended-release tablets CV as once-daily therapy for the management of neuropathic pain associated with diabetic peripheral neuropathy and the management of postherpetic neuralgia. LYRICA CR did not receive approval for the management of fibromyalgia.

The efficacy and safety of LYRICA CR in postherpetic neuralgia was established in a randomized placebo-controlled clinical trial conducted in a total of 801 patients with postherpetic neuralgia who entered single-blind treatment with LYRICA CR.

Copyright RTT News/dpa-AFX

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Last Chance
Oct 23: Vitamin D Primer for Pharmacy Professionals
Oct 24: Metabolic Syndrome: The Heart of Any Wellness Practice
Oct 25: Dispensing Controlled Substances in Today’s Pharmacy
Oct 26: Management of Schizophrenia & Acute Agitation
Oct 27: Influenza 2017-2018: An Update on Prevention and Treatment
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.

Websites »
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement